Global B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size, Status and Forecast 2021-2027

Global B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Bispecific Antibodies
1.2.3 Antibody Drug Conjugates
1.2.4 Chimeric Antigen Receptor T-Cells
1.3 Market by Application
1.3.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Liver Cancer
1.3.3 Respiratory Cancer
1.3.4 Brain Cancer
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Perspective (2016-2027)
2.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Growth Trends by Regions
2.2.1 B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Historic Market Share by Regions (2016-2021)
2.2.3 B-Cell Maturation Antigen(BCMA) Targeted Therapies Forecasted Market Size by Regions (2022-2027)
2.3 B-Cell Maturation Antigen(BCMA) Targeted Therapies Industry Dynamic
2.3.1 B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Trends
2.3.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Drivers
2.3.3 B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Challenges
2.3.4 B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top B-Cell Maturation Antigen(BCMA) Targeted Therapies Players by Revenue
3.1.1 Global Top B-Cell Maturation Antigen(BCMA) Targeted Therapies Players by Revenue (2016-2021)
3.1.2 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Market Share by Players (2016-2021)
3.2 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue
3.4 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Concentration Ratio
3.4.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue in 2020
3.5 B-Cell Maturation Antigen(BCMA) Targeted Therapies Key Players Head office and Area Served
3.6 Key Players B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Solution and Service
3.7 Date of Enter into B-Cell Maturation Antigen(BCMA) Targeted Therapies Market
3.8 Mergers & Acquisitions, Expansion Plans
4 B-Cell Maturation Antigen(BCMA) Targeted Therapies Breakdown Data by Type
4.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Historic Market Size by Type (2016-2021)
4.2 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Forecasted Market Size by Type (2022-2027)
5 B-Cell Maturation Antigen(BCMA) Targeted Therapies Breakdown Data by Application
5.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Historic Market Size by Application (2016-2021)
5.2 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size (2016-2027)
6.2 North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Type
6.2.1 North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Type (2016-2021)
6.2.2 North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Type (2022-2027)
6.2.3 North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Type (2016-2027)
6.3 North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application
6.3.1 North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application (2016-2021)
6.3.2 North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application (2022-2027)
6.3.3 North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application (2016-2027)
6.4 North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Country
6.4.1 North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Country (2016-2021)
6.4.2 North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size (2016-2027)
7.2 Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Type
7.2.1 Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Type (2016-2021)
7.2.2 Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Type (2022-2027)
7.2.3 Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Type (2016-2027)
7.3 Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application
7.3.1 Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application (2016-2021)
7.3.2 Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application (2022-2027)
7.3.3 Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application (2016-2027)
7.4 Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Country
7.4.1 Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Country (2016-2021)
7.4.2 Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size (2016-2027)
8.2 Asia-Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Type
8.2.1 Asia-Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Type (2016-2021)
8.2.2 Asia-Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Type (2022-2027)
8.2.3 Asia-Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Type (2016-2027)
8.3 Asia-Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application
8.3.1 Asia-Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application (2016-2021)
8.3.2 Asia-Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application (2022-2027)
8.3.3 Asia-Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application (2016-2027)
8.4 Asia-Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Region
8.4.1 Asia-Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Region (2016-2021)
8.4.2 Asia-Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size (2016-2027)
9.2 Latin America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Type
9.2.1 Latin America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Type (2016-2021)
9.2.2 Latin America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Type (2022-2027)
9.2.3 Latin America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Type (2016-2027)
9.3 Latin America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application
9.3.1 Latin America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application (2016-2021)
9.3.2 Latin America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application (2022-2027)
9.3.3 Latin America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application (2016-2027)
9.4 Latin America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Country
9.4.1 Latin America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Country (2016-2021)
9.4.2 Latin America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size (2016-2027)
10.2 Middle East & Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Type
10.2.1 Middle East & Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Type (2016-2021)
10.2.2 Middle East & Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Type (2022-2027)
10.2.3 Middle East & Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Type (2016-2027)
10.3 Middle East & Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application
10.3.1 Middle East & Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application (2016-2021)
10.3.2 Middle East & Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application (2022-2027)
10.3.3 Middle East & Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application (2016-2027)
10.4 Middle East & Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Country
10.4.1 Middle East & Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Country (2016-2021)
10.4.2 Middle East & Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Transposagen Biopharmaceuticals
11.1.1 Transposagen Biopharmaceuticals Company Details
11.1.2 Transposagen Biopharmaceuticals Business Overview
11.1.3 Transposagen Biopharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Introduction
11.1.4 Transposagen Biopharmaceuticals Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2016-2021)
11.1.5 Transposagen Biopharmaceuticals Recent Development
11.2 Sutro Biopharma
11.2.1 Sutro Biopharma Company Details
11.2.2 Sutro Biopharma Business Overview
11.2.3 Sutro Biopharma B-Cell Maturation Antigen(BCMA) Targeted Therapies Introduction
11.2.4 Sutro Biopharma Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2016-2021)
11.2.5 Sutro Biopharma Recent Development
11.3 Malin Corporation
11.3.1 Malin Corporation Company Details
11.3.2 Malin Corporation Business Overview
11.3.3 Malin Corporation B-Cell Maturation Antigen(BCMA) Targeted Therapies Introduction
11.3.4 Malin Corporation Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2016-2021)
11.3.5 Malin Corporation Recent Development
11.4 Eureka Therapeutics
11.4.1 Eureka Therapeutics Company Details
11.4.2 Eureka Therapeutics Business Overview
11.4.3 Eureka Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Introduction
11.4.4 Eureka Therapeutics Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2016-2021)
11.4.5 Eureka Therapeutics Recent Development
11.5 firstVentury Equity
11.5.1 firstVentury Equity Company Details
11.5.2 firstVentury Equity Business Overview
11.5.3 firstVentury Equity B-Cell Maturation Antigen(BCMA) Targeted Therapies Introduction
11.5.4 firstVentury Equity Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2016-2021)
11.5.5 firstVentury Equity Recent Development
11.6 Five Prime Therapeutics
11.6.1 Five Prime Therapeutics Company Details
11.6.2 Five Prime Therapeutics Business Overview
11.6.3 Five Prime Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Introduction
11.6.4 Five Prime Therapeutics Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2016-2021)
11.6.5 Five Prime Therapeutics Recent Development
11.7 Credit Suisse Securities
11.7.1 Credit Suisse Securities Company Details
11.7.2 Credit Suisse Securities Business Overview
11.7.3 Credit Suisse Securities B-Cell Maturation Antigen(BCMA) Targeted Therapies Introduction
11.7.4 Credit Suisse Securities Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2016-2021)
11.7.5 Credit Suisse Securities Recent Development
11.8 Dana-Farber Cancer Institute
11.8.1 Dana-Farber Cancer Institute Company Details
11.8.2 Dana-Farber Cancer Institute Business Overview
11.8.3 Dana-Farber Cancer Institute B-Cell Maturation Antigen(BCMA) Targeted Therapies Introduction
11.8.4 Dana-Farber Cancer Institute Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2016-2021)
11.8.5 Dana-Farber Cancer Institute Recent Development
11.9 Deerfield Partners
11.9.1 Deerfield Partners Company Details
11.9.2 Deerfield Partners Business Overview
11.9.3 Deerfield Partners B-Cell Maturation Antigen(BCMA) Targeted Therapies Introduction
11.9.4 Deerfield Partners Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2016-2021)
11.9.5 Deerfield Partners Recent Development
11.10 Onyx Pharmaceuticals
11.10.1 Onyx Pharmaceuticals Company Details
11.10.2 Onyx Pharmaceuticals Business Overview
11.10.3 Onyx Pharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Introduction
11.10.4 Onyx Pharmaceuticals Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2016-2021)
11.10.5 Onyx Pharmaceuticals Recent Development
11.11 Juno Therapeutics
11.11.1 Juno Therapeutics Company Details
11.11.2 Juno Therapeutics Business Overview
11.11.3 Juno Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Introduction
11.11.4 Juno Therapeutics Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2016-2021)
11.11.5 Juno Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Bispecific Antibodies
Table 3. Key Players of Antibody Drug Conjugates
Table 4. Key Players of Chimeric Antigen Receptor T-Cells
Table 5. Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Regions (2016-2021)
Table 9. Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Regions (2022-2027)
Table 11. B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Trends
Table 12. B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Drivers
Table 13. B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Challenges
Table 14. B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Restraints
Table 15. Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Players (2016-2021)
Table 17. Global Top B-Cell Maturation Antigen(BCMA) Targeted Therapies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies as of 2020)
Table 18. Ranking of Global Top B-Cell Maturation Antigen(BCMA) Targeted Therapies Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Solution and Service
Table 22. Date of Enter into B-Cell Maturation Antigen(BCMA) Targeted Therapies Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Type (2016-2021) (US$ Million)
Table 25. Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Market Share by Type (2016-2021)
Table 26. Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Market Share by Application (2016-2021)
Table 30. Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Type (2016-2021) (US$ Million)
Table 33. North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application (2016-2021) (US$ Million)
Table 35. North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Country (2022-2027) & (US$ Million)
Table 62. Transposagen Biopharmaceuticals Company Details
Table 63. Transposagen Biopharmaceuticals Business Overview
Table 64. Transposagen Biopharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Product
Table 65. Transposagen Biopharmaceuticals Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2016-2021) & (US$ Million)
Table 66. Transposagen Biopharmaceuticals Recent Development
Table 67. Sutro Biopharma Company Details
Table 68. Sutro Biopharma Business Overview
Table 69. Sutro Biopharma B-Cell Maturation Antigen(BCMA) Targeted Therapies Product
Table 70. Sutro Biopharma Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2016-2021) & (US$ Million)
Table 71. Sutro Biopharma Recent Development
Table 72. Malin Corporation Company Details
Table 73. Malin Corporation Business Overview
Table 74. Malin Corporation B-Cell Maturation Antigen(BCMA) Targeted Therapies Product
Table 75. Malin Corporation Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2016-2021) & (US$ Million)
Table 76. Malin Corporation Recent Development
Table 77. Eureka Therapeutics Company Details
Table 78. Eureka Therapeutics Business Overview
Table 79. Eureka Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Product
Table 80. Eureka Therapeutics Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2016-2021) & (US$ Million)
Table 81. Eureka Therapeutics Recent Development
Table 82. firstVentury Equity Company Details
Table 83. firstVentury Equity Business Overview
Table 84. firstVentury Equity B-Cell Maturation Antigen(BCMA) Targeted Therapies Product
Table 85. firstVentury Equity Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2016-2021) & (US$ Million)
Table 86. firstVentury Equity Recent Development
Table 87. Five Prime Therapeutics Company Details
Table 88. Five Prime Therapeutics Business Overview
Table 89. Five Prime Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Product
Table 90. Five Prime Therapeutics Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2016-2021) & (US$ Million)
Table 91. Five Prime Therapeutics Recent Development
Table 92. Credit Suisse Securities Company Details
Table 93. Credit Suisse Securities Business Overview
Table 94. Credit Suisse Securities B-Cell Maturation Antigen(BCMA) Targeted Therapies Product
Table 95. Credit Suisse Securities Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2016-2021) & (US$ Million)
Table 96. Credit Suisse Securities Recent Development
Table 97. Dana-Farber Cancer Institute Company Details
Table 98. Dana-Farber Cancer Institute Business Overview
Table 99. Dana-Farber Cancer Institute Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2016-2021) & (US$ Million)
Table 100. Dana-Farber Cancer Institute Recent Development
Table 101. Deerfield Partners Company Details
Table 102. Deerfield Partners Business Overview
Table 103. Deerfield Partners B-Cell Maturation Antigen(BCMA) Targeted Therapies Product
Table 104. Deerfield Partners Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2016-2021) & (US$ Million)
Table 105. Deerfield Partners Recent Development
Table 106. Onyx Pharmaceuticals Company Details
Table 107. Onyx Pharmaceuticals Business Overview
Table 108. Onyx Pharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Product
Table 109. Onyx Pharmaceuticals Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2016-2021) & (US$ Million)
Table 110. Onyx Pharmaceuticals Recent Development
Table 111. Juno Therapeutics Company Details
Table 112. Juno Therapeutics Business Overview
Table 113. Juno Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Product
Table 114. Juno Therapeutics Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2016-2021) & (US$ Million)
Table 115. Juno Therapeutics Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Type: 2020 VS 2027
Figure 2. Bispecific Antibodies Features
Figure 3. Antibody Drug Conjugates Features
Figure 4. Chimeric Antigen Receptor T-Cells Features
Figure 5. Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Application: 2020 VS 2027
Figure 6. Liver Cancer Case Studies
Figure 7. Respiratory Cancer Case Studies
Figure 8. Brain Cancer Case Studies
Figure 9. Others Case Studies
Figure 10. B-Cell Maturation Antigen(BCMA) Targeted Therapies Report Years Considered
Figure 11. Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Regions: 2020 VS 2027
Figure 14. Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Regions (2022-2027)
Figure 15. Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Players in 2020
Figure 16. Global Top B-Cell Maturation Antigen(BCMA) Targeted Therapies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies as of 2020
Figure 17. The Top 10 and 5 Players Market Share by B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue in 2020
Figure 18. Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Market Share by Type (2016-2021)
Figure 19. Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Market Share by Type (2022-2027)
Figure 20. North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Type (2016-2027)
Figure 22. North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Application (2016-2027)
Figure 23. North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Country (2016-2027)
Figure 24. United States B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Type (2016-2027)
Figure 28. Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Application (2016-2027)
Figure 29. Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Country (2016-2027)
Figure 30. Germany B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Type (2016-2027)
Figure 38. Asia-Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Application (2016-2027)
Figure 39. Asia-Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Region (2016-2027)
Figure 40. China B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Type (2016-2027)
Figure 48. Latin America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Application (2016-2027)
Figure 49. Latin America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Country (2016-2027)
Figure 50. Mexico B-Cell M

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs